# SafeBoosC - a Phase II Trial

> **NCT01590316** · NA · COMPLETED · sponsor: **Gorm Greisen** · enrollment: 165 (estimated)

## Conditions studied

- Brain Injuries
- Infant, Premature

## Interventions

- **DEVICE:** Cerebral NIRS oximetry

## Key facts

- **NCT ID:** NCT01590316
- **Lead sponsor:** Gorm Greisen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-12
- **Final completion:** 2018-03
- **Target enrollment:** 165 (ESTIMATED)
- **Last updated:** 2018-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01590316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01590316, "SafeBoosC - a Phase II Trial". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01590316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*